Pay in 4 interest-free payments of $6.80 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Bridging the gap between gut microbial dysbiosis and cardiovascular diseases
PMID 15043988
The therapeutic approach to target the incretin system for the treatment of type 2 diabetes involves the use of GLP-1 agonists or DPP-4 inhibitors to increase the levels of endogenous GLP-1 ( In addition to pancreatic localization, GLP-1R has been found in the gastrointestinal system, kidneys, central nervous system, and cardiovascular system (Pyke et al., 2014)
Studies show that L-Theanine helps increase alpha brain wave activity, thereby promoting relaxation and mental alertness
When your digestive system breaks down food, or when you are exposed to environmental toxins like cigarette smoke or radiation, you produce molecules with unpaired electrons called free radicals
GLP-1 is a hormone that helps regulate blood sugar levels by stimulating insulin release and reducing the amount of glucose produced by the liver
US$ 28.09
US$ 22.89
US$ 20.12
US$ 24.50
US$ 20.40
US$ 28.73
US$ 29.94
US$ 28.96
